Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sophie Smart"'
Autor:
Rebecca Owens, Rebecca Pollard, Richard Drake, Laura Kassoumeri, Shon Lewis, James MacCabe, Oliver D Howes, Edward Millgate, Eugenia Kravariti, Alice Egerton, Jane Lees, Bill Deakin, Kira Griffiths, Cecilia Casetta, Sobia Khan, Steve Lankshear, Elena Mikulskaya, Ebenezer Oloyede, Nathalie Rich, Sophie Smart, Aviv Segev, Kyra Verena Sendt
Publikováno v:
BMJ Open, Vol 12, Iss 11 (2022)
Objectives This prospective cohort study tested for associations between baseline cognitive performance in individuals early within their first episode and antipsychotic treatment of psychosis. We hypothesised that poorer cognitive functioning at the
Externí odkaz:
https://doaj.org/article/24b84b4f0e3248a4be25b8fa5a018358
Autor:
Eugenia Kravariti, Amy Gillespie, Kelly Diederen, Sophie Smart, Caroline Mayberry, Alan Meehan, Danielle Bream, Peter Musiat, Silia Vitoraou, Daniel Stahl, Kyle Dyer, Sukhi Sukhwinder, Kelly Coate, Jenny Yiend
Publikováno v:
Teaching & Learning Inquiry: The ISSOTL Journal, Vol 6, Iss 2, Pp 143-164 (2018)
As internet access and use increase exponentially, pedagogical practice becomes increasingly embedded in online platforms. We report on an online initiative of engaged student learning, the peer-led, staff-assisted e-helpdesk for research methods and
Externí odkaz:
https://doaj.org/article/cacde76fe81e4296a5817c509209a7c0
Autor:
Grace Woolway, Sophie Legge, Amy Lynham, Sophie Smart, Leon Hubbard, Michael O'Donovan, Michael Owen, Ian Jones, James Walters
Publikováno v:
European Neuropsychopharmacology. 63:e226-e227
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a25bce4a9d1707fc8e5ca822505ea0c3
https://doi.org/10.1016/j.euroneuro.2022.07.404
https://doi.org/10.1016/j.euroneuro.2022.07.404
Autor:
Carly Samson, Matthew R. Broome, Paola Dazzan, Oliver D. Howes, Sarah E. Morgan, Beverly Quinn, Jesus Perez, Mathilde Antoniades, James M. Stone, Anthony A. Grace, Ilaria Bonoldi, Paul Allen, Philip McGuire, Matthijs G. Bossong, Nicolas Crossley, Matilda Azis, Sophie Smart, George Gifford, Gemma Modinos, Matthew J. Kempton
Publikováno v:
Human Brain Mapping
The ability to identify biomarkers of psychosis risk is essential in defining effective preventive measures to potentially circumvent the transition to psychosis. Using samples of people at clinical high risk for psychosis (CHR) and Healthy controls
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1edea8937388ca5e576fd3af78ea7ca7
https://doi.org/10.1002/hbm.25235
https://doi.org/10.1002/hbm.25235
Autor:
Steve Kisely, Stacy Orr, Bhavna Brijball, Surabhi Sinha, James H. MacCabe, Dan Siskind, Ou Yu, Sophie Smart, Nicola Warren
Publikováno v:
Siskind, D, Orr, S, Sinha, S, Yu, O, Brijball, B, Warren, N, MacCabe, J H, Smart, S E & Kisely, S 2021, ' Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis ', The British journal of psychiatry : the journal of mental science, pp. 1-6 . https://doi.org/10.1192/bjp.2021.61
BackgroundTreatment-resistant schizophrenia (TRS) is associated with high levels of functional impairment, healthcare usage and societal costs. Cross-sectional studies may overestimate TRS rates because of selection bias.AimsWe aimed to quantify TRS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::637fdc081239a5db2ec34511495c65e0
https://pubmed.ncbi.nlm.nih.gov/35049446
https://pubmed.ncbi.nlm.nih.gov/35049446
Autor:
Edward Millgate, Kira Griffiths, Alice Egerton, Eugenia Kravariti, Cecilia Casetta, Bill Deakin, Richard Drake, Oliver D Howes, Laura Kassoumeri, Sobia Khan, Steve Lankshear, Jane Lees, Shon Lewis, Elena Mikulskaya, Ebenezer Oloyede, Rebecca Owens, Rebecca Pollard, Nathalie Rich, Sophie Smart, Aviv Segev, Kyra Verena Sendt, James MacCabe
Publikováno v:
BMJ Open. 12:e062570
ObjectivesThis prospective cohort study tested for associations between baseline cognitive performance in individuals early within their first episode and antipsychotic treatment of psychosis. We hypothesised that poorer cognitive functioning at the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d6fbb41f3ac6f72e64f02c07981ed6f
https://doi.org/10.1136/bmjopen-2022-062570
https://doi.org/10.1136/bmjopen-2022-062570
Autor:
Giorgio Pistis, Javier Vázquez-Bourgon, Margot Fournier, Raoul Jenni, Martine Cleusix, Sergi Papiol, Sophie Smart, Antonio Pardiñas, James Walters, James MacCabe, Zoltan Kutalik, Philippe Conus, Benedicto Crespo-Facorro, Kim Do
Publikováno v:
European Neuropsychopharmacology. 63:e175
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93334bf0a0b596a045a94957df622b6c
https://doi.org/10.1016/j.euroneuro.2022.07.317
https://doi.org/10.1016/j.euroneuro.2022.07.317
Publikováno v:
Smart, S E, Kepinska, A P, Murray, R M & MacCabe, J H 2019, ' Predictors of Treatment Resistant Schizophrenia : a systematic review of prospective observational studies ', Psychological Medicine . https://doi.org/10.1017/S0033291719002083
Psychological Medicine
Psychological Medicine
Treatment-resistant schizophrenia, affecting approximately 20–30% of patients with schizophrenia, has a high burden both for patients and healthcare services. There is a need to identify treatment resistance earlier in the course of the illness, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9046a21ea951a57aecac1117475f515c
https://doi.org/10.1017/s0033291719002083
https://doi.org/10.1017/s0033291719002083
Publikováno v:
European Neuropsychopharmacology. 51:e184
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9ba90777ca38d0d3868aae0aa26b6c2
https://doi.org/10.1016/j.euroneuro.2021.08.160
https://doi.org/10.1016/j.euroneuro.2021.08.160
Autor:
Sophie Smart, Deborah Agbedjro, STRATA-G Consortium, Antonio Pardinas, James Walters, Daniel Stahl, Robin Murray, James MacCabe
BACKGROUND: Within clinical services, there can be a delay of years before patients with psychosis, who do not respond to antipsychotic medication, receive a diagnosis of treatment resistant schizophrenia (TRS). There is a need to identify these pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eede25521ee57b6616fc5f8925914e41
https://europepmc.org/articles/PMC6455335/
https://europepmc.org/articles/PMC6455335/
